Palvella Therapeutics
Rare disease biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
€205m (Public information from Jan 2023)
Radnor Township Pennsylvania (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | - | ||
N/A | $4.4m | Early VC | |
* | $10.0m | Early VC | |
* | $45.0m | Series C | |
* | $9.7m Valuation: $225m | Series D | |
* | N/A | N/A | IPO |
* | $78.9m | Post IPO Equity | |
Total Funding | €62.8m |
Related Content
Recent News about Palvella Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Palvella Therapeutics
EditACQUISITION by Palvella Therapeutics Jul 2024